The Minister of Health announces a reduction in drug reimbursement in 2025

The Minister of Health announces a reduction in drug reimbursement in 2025
The Minister of Health announces a reduction in drug reimbursement in 2025

By Le Figaro with AFP

Published
34 minutes ago,

updated at 5:18 p.m


data-script=”https://static.lefigaro.fr/widget-video/short-ttl/video/index.js”
>

Geneviève Darrieusecq made this announcement this Monday at the opening of the debates on the draft Social Security budget for 2025. Medical consultations are also concerned.

The reimbursement rate for medicines by Social Security will drop by 5% next year, as will the coverage of medical consultations, announced the Minister of Health Geneviève Darrieussecq this Monday in the Senate. THE “moderator fee”most often the responsibility of complementary health insurance, “will only change by 5%” for medical consultations then “that it was potentially possible to increase it by 10%”more “in addition (that) on medicines will increase by 5%”explained the minister at the opening of the debates on the draft Social Security budget for 2025.

These dereimbursements, which do not appear in the text but will be recorded by ministerial decree, will result in a “transfer to complementary health insurance” whose amount “was reduced from 1.1 billion to 900 million euros” she clarified. The government's initial project consisted of reducing the cost of medical consultations from 70% to 60%, which will therefore be reimbursed at 65% in the future. For medicines, the three existing reimbursement rates (65%, 30% and 15%) would a priori be lowered in the same proportion. In addition, to achieve a savings objective “to the tune of 5 billion euros” on health spending, “we are also considering price reductions for health products amounting to 1.2 billion euros”as well as “efficiency measures at the hospital” for 600 million and also on city care for 600 million, added Ms. Darrieussecq.

Furthermore, the Minister of Health confirmed a “skid” drug expenses this year, “valued at 1.2 billion euros”which the government intends to limit after a “dialogue with manufacturers in order to find compensation mechanisms”. The financial contribution of pharmaceutical laboratories, via the “escape clause” of the sector, would not “activated only in the event of failure of the process”she assured. His colleague from Public Accounts, Laurent Saint-Martin, then clarified that the “different levers” under study must make it possible to “reduce the overrun compared to the trajectory presented to 200 million euros” in the Social Security budget for 2025.

-

-

PREV the December 15 visit made official by the Vatican
NEXT Climate: after the anger of poor countries, negotiations continue at night in Baku: News